Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Beatty

Showing results (1-10 of 367) with videos related to

Pageof 37
Sort By:
Oncoimmunology|February 7, 2014
Macrophage-based immunotherapy for the treatment of pancreatic ductal adenocarcinomaGregory L Beatty
Journal of Cell Science|January 18, 2006
Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatisWandy L Beatty
Cellular Microbiology|April 25, 2007
Lysosome repair enables host cell survival and bacterial persistence following Chlamydia trachomatis infectionWandy L Beatty
Infection and Immunity|April 23, 2008
Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63Wandy L Beatty
Oncoimmunology|July 23, 2014
Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinomaGregory L Beatty
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Overcoming Therapeutic Resistance by Targeting Cancer InflammationGregory L Beatty
Cancers|July 2, 2021
Serum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in CancerJesse Lee, Gregory L Beatty
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigenG L Beatty, Y Paterson
Immunologic Research|October 12, 2001
Regulation of tumor growth by IFN-gamma in cancer immunotherapyG L Beatty, Y Paterson
JCO Clinical Cancer Informatics|July 9, 2025
Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient PortalJes Alexander, Alexis L Beatty
Pageof 37

Showing results (1-10 of 367) with videos related to

Sort By:
Pageof 37
Oncoimmunology|February 7, 2014
Macrophage-based immunotherapy for the treatment of pancreatic ductal adenocarcinomaGregory L Beatty
Journal of Cell Science|January 18, 2006
Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatisWandy L Beatty
Cellular Microbiology|April 25, 2007
Lysosome repair enables host cell survival and bacterial persistence following Chlamydia trachomatis infectionWandy L Beatty
Infection and Immunity|April 23, 2008
Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63Wandy L Beatty
Oncoimmunology|July 23, 2014
Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinomaGregory L Beatty
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Overcoming Therapeutic Resistance by Targeting Cancer InflammationGregory L Beatty
Cancers|July 2, 2021
Serum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in CancerJesse Lee, Gregory L Beatty
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigenG L Beatty, Y Paterson
Immunologic Research|October 12, 2001
Regulation of tumor growth by IFN-gamma in cancer immunotherapyG L Beatty, Y Paterson
JCO Clinical Cancer Informatics|July 9, 2025
Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient PortalJes Alexander, Alexis L Beatty
Pageof 37